174 related articles for article (PubMed ID: 11658101)
1. Bias in science and medical knowledge: the Opren controversy.
Abraham J
Sociology; 1994 Aug; 28(3):717-36. PubMed ID: 11658101
[No Abstract] [Full Text] [Related]
2. Criminal liability for misconduct in scientific research.
Kuzma SM
Univ Mich J Law Reform; 1992; 25(2):357-421. PubMed ID: 11651584
[No Abstract] [Full Text] [Related]
3. Opren deaths kept secret, admits Lilly.
Joyce C; Lesser F
New Sci; 1985 Aug; 107(1471):15-6. PubMed ID: 11655708
[No Abstract] [Full Text] [Related]
4. Ethical aspects of the safety of medicines and other social chemicals.
Parke DV
Sci Eng Ethics; 1995 Jul; 1(3):283-98. PubMed ID: 11657782
[No Abstract] [Full Text] [Related]
5. Research project on ear infections dramatizes challenge of conflicts.
Cordes C
Chron High Educ; 1993 Mar; 39(26):A23, A28. PubMed ID: 11656295
[No Abstract] [Full Text] [Related]
6. Character and the ethical conduct of research.
Pellegrino ED
Account Res; 1992; 2(1):1-11. PubMed ID: 11651456
[No Abstract] [Full Text] [Related]
7. A doctor's drug studies turn into fraud.
Eichenwald K; Kolata G
N Y Times Web; 1999 May; ():A1, A16. PubMed ID: 11647660
[No Abstract] [Full Text] [Related]
8. US drug regulation: Congress finds FDA wanting.
Budiansky S
Nature; 1982 Aug; 298(5875):597-8. PubMed ID: 11643777
[TBL] [Abstract][Full Text] [Related]
9. Fraud and misconduct in clinical research: is it prejudicial to patient safety?
Wells F
Adverse Drug React Acute Poisoning Rev; 1992; 11(4):241-55. PubMed ID: 11652183
[No Abstract] [Full Text] [Related]
10. Policies and quality assurance in the pharmaceutical industry.
Shamoo AE
Account Res; 1991; 1(4):273-84. PubMed ID: 11651459
[No Abstract] [Full Text] [Related]
11. United States: protecting the integrity of research.
Sibbison JB
Lancet; 1989 Nov; 2(8671):1094. PubMed ID: 11644437
[No Abstract] [Full Text] [Related]
12. Fraud in drug research.
Brahams D
Lancet; 1992 Aug; 340(8817):477-8. PubMed ID: 11643085
[No Abstract] [Full Text] [Related]
13. Data audit by a regulatory agency: its effect and implication for others.
Shapiro MF
Account Res; 1992; 2(3):219-29. PubMed ID: 11653981
[No Abstract] [Full Text] [Related]
14. Scientific misconduct: a form of white coat crime.
Kline S
J Pharm Law; 1993; 2(1):15-34. PubMed ID: 11653114
[No Abstract] [Full Text] [Related]
15. Medical research has its downsides.
Bull Med Ethics; 1999 Nov; No. 152():6-7. PubMed ID: 11658084
[No Abstract] [Full Text] [Related]
16. Innovation and integrity in biomedical research.
Jasanoff S
Acad Med; 1993 Sep; 69(9 Suppl):S91-5. PubMed ID: 11652808
[No Abstract] [Full Text] [Related]
17. Pitching doctors.
Wilkes MS; Shuchman M
N Y Times Mag; 1989 Nov; ():88, 90, 126, 128-129. PubMed ID: 11650264
[No Abstract] [Full Text] [Related]
18. New rules will force doctors to disclose ties to drug industry.
Stolberg SG
N Y Times Web; 1998 Feb; ():A12. PubMed ID: 11647602
[No Abstract] [Full Text] [Related]
19. Data monitoring committees: the moral case for maximum feasible independence.
Walters L
Stat Med; 1993 Mar; 12(5-6):575-80. PubMed ID: 11659537
[No Abstract] [Full Text] [Related]
20. Competing interests: the need to control conflict of interests in biomedical research.
Steiner D
Sci Eng Ethics; 1996 Oct; 2(4):457-68. PubMed ID: 11657732
[No Abstract] [Full Text] [Related]
[Next] [New Search]
